Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: Results of a prospective, double-blind, placebo-randomized study

Transplantation

Volumn 75, Issue 7, 2003, Pages 977-982

  Cadranel, Jean François ^a   Di Martino, Vincent ^b   Dorent, Richard ^b   Bernard, Brigitte ^b   Hoang, Catherine ^b   Myara, Anne ^c   Pauwels, Arnaud ^d   Ghoussoub, Jean Jacques ^b   Perrin, Michèle ^b   Grippon, Patrick ^b   Thabut, Dominique ^a   Trivin, Franco̧is ^c   Huraux, Jean Marie ^b   Gandjbakhch, Iradj ^b   Opolon, Pierre ^b   Lunel, Françoise ^e  

^a CENTRE HOSPITALIER LAENNEC   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SAINT JOSEPH HOSPITAL   (France)

^d CENTRE HOSPITALIER DE GONESSE   (France)

^e Service de Virologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; PLACEBO; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EPIGASTRIC PAIN; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GOUT; GRAFT REJECTION; HEART TRANSPLANTATION; HEPATITIS B; HEPATITIS C; HEPATITIS NON A TO G; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LIVER HISTOLOGY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; SCORING SYSTEM; SIDE EFFECT; VIRUS HEPATITIS;

EID: 0345700745     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000055831.63841.B6     Document Type: Article

References (30)

1. Cadranel JF, Grippon P, Lunel F, et al. Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C, and non-A, non-B, non-C hepatitis: a retrospective study in 80 patients with follow-up of 60 months. Transplantation 1991; 52: 645-650.
2. Lunel F, Cadranel JF, Rosenheim M, et al. Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival. Gastroenterology, 2000; 119: 1064-1074.
3. Osterhaus ADME, Vos MC, Balk AHMM, et al. Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures. J Heart Lung Transplant 1998; 17: 158-166.
4. Drescher J, Wagner D, Haverich A, et al. Nosocomial hepatitis B virus infections in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy. J Hosp Infect 1994; 81: 92.
5. Cadranel JF, Lunel F, Perrin M, et al. Is postoperative HBV hepatitis in heart transplant recipients the fruit of hazard? Gastroenterol Clin Biol 1990; 14: 848-849.
6. Cadranel JF, Lunel F, Perrin M, et al. Prévalence élevée de l'hépatite B après transplantation cardiaque: absence d'argument pour une contamination transfusionnelle. Gastroenterol Clin Biol 1992; 16: 1-5.
7. Wedemeyer H, Pethig K, Wagner D, et al. Long-term outcome of chronic hepatitis B in heart transplant recipients. Transplantation 1998; 66: 1347-1353.
8. Lunel F, Cadranel JF, Perrin M, et al. Anti-hepatitis C virus (HCV) antibodies in heart transplant recipients with posttransplantation chronic viral B and non-A, non-B hepatitis. Dig Dis Sci 1991; 36: 124-125.
9. Ong JP, Barnes DS, Younossi ZM, et al. Outcome of de novo hepatitis C virus infection in heart transplant recipients. Hepatology 1999; 30: 1293-1298.
10. Pol S, Samuel D, Cadranel JF, et al. Hepatitis and solid organ transplantation. Transplant Proc 2000; 32: 454-457.
11. Lunel F, Robert C, Munier P, et al. Hepatitis virus infections in heart transplant recipients. Biomed Pharmacother 1995; 49: 125-129.
12. Wedemeyer H, Pethig K, Manns MP, et al. Hepatitis B infection in heart transplant recipients. Gastroenterology 2001; 120: 1311-1312.
13. Di Martino V, Rosenheim M, Dorent R, et al. Hepatitis B infection in heart transplant recipients [reply]. Gastroenterology 2001; 120: 1313.
14. Slater AD, Klein JB, Sonnenfeld G, et al. The effects of interferon-alpha/beta in a model of rat heart transplantation. J Heart Lung Transplant 1992; 11: 975-978.
15. Durlik M, Rancewicz Z, Gaciong Z, et al. Treatment of chronic hepatitis B and C with interferon-alpha in renal allograft recipients: preliminary results. Transpl.Int 1994; 7(suppl): S343-S345.
16. Poupon R, Poupon RE. Treatment of primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 615-628.
17. Calmus Y, Gane P, Rouger P, et al. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990; 11: 12-15.
18. Simko V, Michael S, Prego V. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis. Am J Gastroenterol. 1994; 89: 392-398.
19. Lirussi F, Beccarello A, Bortolato L, et al. Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease. Liver 1999; 19: 381-388.
20. Puoti C, Magrini A, Filippi T, et al. Effects of ursodeoxycholic acid on serum liver enzymes in patients with hepatitis C virus-related chronic liver disease. Eur J Gastroenterol Hepatol 1995; 7: 151-154.
21. Bellentani S, Podda M, Tiribelli C, et al. Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial. J Hepatol 1993; 19: 459-464.
22. Podda M, Ghezzi C, Battezzati PM, et al. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology 1990; 98: 1044-1050.
23. Crosignani A, Battezzati PM, Setchell KD, et al. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study. Hepatology 1991; 13: 339-344.
24. Cadranel JF, Erlinger S, Desruenne M, et al. Chronic administration of cyclosporin A induces a decrease in hepatic excretory function in man. Dig Dis Sci 1992; 37: 1473-6.
25. Myara A, Cadranel JF, Dorent R, et al. Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation. Eur J Gastroenterol Hepatol 1996; 8: 267-271.
26. Queneau PE, Bertault-Peres P, Guitaoui M, et al. Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat. Dig Dis Sci 1994; 39: 1581-1585.
27. Kallinowski B, Theilmann L, Zimmermann R, et al. Effective treatment of cyclosporine-induced cholestasis in heart-transplanted patients treated with ursodeoxycholic acid. Transplantation 1991; 51: 1128-1129.
28. Cadranel JF, Grippon P, Mattei MF, et al. Prevalence and causes of long-lasting hepatic dysfunction after heart transplantation: a series of 80 patients. Artif Organs 1988; 12: 234-238.
29. Stuyver L, De Gendt S, Cadranel JF, et al. Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus. Hepatology 1999; 29:1876-1883.
30. Chretien Y, Poupon R, Gherardt MF, et al. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment. Gut 1989; 30: 1110-1115.